Influence of the timing of biological treatment initiation on Juvenile Idiopathic Arthritis long-term outcomes.
Filipa Oliveira-RamosAna Maria RodriguesAna Teresa MeloFrancisca AguiarLuísa BritesSoraia AzevedoAna Catarina DuarteJosé António Melo GomesCarolina FurtadoAna Filipa MourãoGraça SequeiraInês CunhaRicardo FigueiraMaria José SantosJoão Eurico FonsecaPublished in: Arthritis research & therapy (2023)
Later initiation of bDMARDs in JIA is associated with a greater physical disability, worse HRQoL, and lower chance of drug-free remission in adulthood.